The Treat@Home research program is a Danish national, interdisciplinary collaboration involving healthcare professionals across regions and sectors, conducted in close partnership with patients and their relatives.
The aim of the program is to generate evidence on the feasibility, effectiveness, and implementation of home-based interventions for patients with hematological malignancies in Denmark. In addition, the program investigates clinical practice, safety, organizational frameworks, health economics, as well as associated barriers and facilitating factors related to the delivery and management of home-based treatment.
Advances in targeted therapies and immunotherapies have improved survival among patients with hematological malignancies. At the same time, these treatments are often associated with a substantial symptom burden, reduced quality of life, and unpredictable treatment trajectories, thereby increasing the demand for hematological healthcare services. Enhancing quality of life and the ability to maintain everyday life with minimal time spent in hospital is of considerable value to the individual patient and also of significant benefit to society. Treat@Home can support and contribute knowledge to the transformation of the Danish healthcare system from hospital-centered models toward decentralized, patient-centered care pathways.
Overview of ongoing research projects
PhD Student: Christian Landbo
Primary Supervisor: Associate Professor, Ph.D., Nurse Kristina Nørskov
Co-Supervisors: Professor, Ph.D., Nurse Mary Jarden; Postdoctoral Researcher, Ph.D., Nurse Iben Husted Nielsen; Associate Professor, Ph.D., Consultant Anne Louise Tøllbøll Sørensen
Objective: To explore and evaluate the practice of home-based treatment with Cytarabine across Danish hematology departments, thereby generating knowledge to support a nationally consistent implementation. The project will examine feasibility, patient safety, quality of life, costs, organizational factors, and perceived barriers and opportunities among patients, relatives, and healthcare professionals.
Start: February 2026
Contact: christian.landbo@regionh.dk
PhD Student: Tine Rosenberg
Primary Supervisor: Associate Professor, Ph.D., Chief Consultant Thomas Lund
Co-Supervisors: Associate Professor, Ph.D., Nurse Kristina Nørskov; Postdoctoral Researcher, Ph.D., Nurse Helle Enggaard; Professor, Consultant Henrik Fredriksen
Objective: To explore and evaluate the practice of home-based treatment with Daratumumab across Danish hematology departments, thereby generating knowledge to support a nationally consistent implementation. The project will examine feasibility, patient safety, quality of life, costs, organizational factors, and perceived barriers and opportunities among patients, relatives, and healthcare professionals.
Start: 2026
Contact: tine.rosenberg@rsyd.dk
Project Leads: MScN, Project Nurse Jannie Kirkegaard & Associate Professor, Ph.D., Nurse Kristina Nørskov
Project Team: Under development
Objective: To explore experiences and perspectives among patients with hematological malignancies who choose not to participate in home-based treatment.
Contact: jannie.kirkegaard@rsyd.dk
Project Leads: Associate Professor, Ph.D., Nurse Kristina Nørskov & MScN, Project Nurse Jannie Kirkegaard
Project Team: Under development
Objective: To examine experiences, needs, and perspectives on home-based treatment among socially vulnerable patients with hematological malignancies.
Contact: knors@regionsjaelland.dk
Project Leads: MScN, Nurse Camilla Thim Damgaard & Postdoctoral Researcher, Ph.D., Nurse Iben Husted Nielsen
Project Team: PhD Student Tine Rosenberg; Postdoctoral Researcher, Ph.D., Nurse Helle Enggaard; PhD Student Christian Landbo; Associate Professor, Ph.D., Nurse Kristina Nørskov
Objective: To identify, discuss, and prioritize future research areas related to home-based treatment of patients with hematological malignancies and their relatives. Additionally, to establish and anchor a national panel of patients and relatives to actively contribute to the planning, execution, and prioritization of future Treat@Home research.
Contact: cathim@rm.dk
Project Leads: PhD Student Maja Kjær Rasmussen & Professor Kristian Kidholm
Project Team: Associate Professor, Ph.D., Chief Consultant Thomas Lund; Associate Professor, Ph.D., Nurse Kristina Nørskov; Postdoctoral Researcher, Ph.D., Nurse Helle Enggaard; Professor, Consultant Henrik Fredriksen; Professor, Ph.D., Nurse Mary Jarden; Postdoctoral Researcher, Ph.D., Nurse Iben Husted Nielsen; Associate Professor, Ph.D., Consultant Anne Louise Tøllbøll Sørensen
Objective: To investigate the health and societal economic implications of home-based treatment with Daratumumab and Cytarabine, aiming to estimate total costs across different organizational models and identify the most cost-effective approaches across Danish hematology departments.
Contact: maja.kjaer.rasmussen@rsyd.dk
